Evaluation of the association between prostate-specific antigen density and systematic prostate biopsy pathological results

PSA-d is a reliable marker for predicting PCa aggressiveness and has better diagnostic accuracy than PSA. Incorporating PSA-d into clinical decision-making may enhance the detection of clinically significant PCa, particularly in resource-limited settings where advanced imaging modalities are unavailable.